July 13 (Reuters) - Xvivo Perfusion AB XVIVO.ST :
* Q2 NET SALES AMOUNTED TO SEK 59.3 MILLION (30.4)
* Q2 NET SALES IN BUSINESS AREA THORACIC AMOUNTED TO SEK
49.9
MILLION (30.3) AND ABDOMINAL SEK 9.4 MILLION
* Q2 ADJUSTED OPERATING PROFIT BEFORE DEPRECIATION AND
AMORTIZATION (EBITDA) AMOUNTED TO SEK 8.4 MILLION (-1.0)
* Q2 NET PROFIT AMOUNTED TO SEK -8.9 MILLION (-16.0)
* Q2 ADJUSTED OPERATING PROFIT (EBIT) AMOUNTED TO SEK 0.6
MILLION
(-8.2)
Source text for Eikon: ID:nMFN5FB2HS
Further company coverage: XVIVO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))